[1]刘世梅,胡 琰,杜景柏,等.以心功能分级为依据的中医分型治疗慢性心力衰竭临床观察[J].西部中医药,2018,31(09):97-99.
　LIU Shimei,HU Yan,DU Jingbai,et al.Clinical Observation on Treating Chronic Congestive Heart Failure by TCM Pattern Treatment on the Foundation of Cardiac Functional Grading[J].Western Journal of Traditional Chinese Medicine,2018,31(09):97-99.
点击复制

以心功能分级为依据的中医分型治疗慢性心力衰竭临床观察()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
31
期数:
2018年09期
页码:
97-99
栏目:
出版日期:
2018-09-15

文章信息/Info

Title:
Clinical Observation on Treating Chronic Congestive Heart Failure by TCM Pattern Treatment on the Foundation of Cardiac Functional Grading
文章编号:
1004-6852(2018)09-0097-03
作者:
刘世梅，胡 琰，杜景柏，滕 云，周德莲
甘肃省中医院白银分院心血管病科，甘肃 白银 730900
Author(s):
LIU Shimei, HU Yan, DU Jingbai, TENG Yun, ZHOU Delian
Department of Cardiovascular Diseases, Baiyin Branch, Gansu Provincial Hospital of Traditional Chinese Medicine, Baiyin 730900, China
关键词:
慢性心力衰竭; 心功能分级; 辨证论治
Keywords:
chronic congestive heart failure;  cardiac functional grading;  syndrome differentiation and treatment
分类号:
R541
文献标志码:
B
摘要:
目的：观察以心功能分级为依据的中医分型治疗慢性心力衰竭(chronic congestive heart failure，CHF)的临床疗效。方法：将CHF患者60例随机分为治疗组和对照组各30例，对照组单纯西医治疗，治疗组在对照组治疗的基础上以心功能分级为辨证论治基础治疗，治疗4周为1个疗程，1个疗程后观察总有效率，血浆氨基末端脑钠肽前体(NT-proBNP)浓度与左室射血分数(Left ventricular ejection fraction，LVEF)。结果：总有效率治疗组为96.7%，对照组为83.3%；2组比较差异有统计学意义(P＜0.05)；2组LVEF治疗后升高(P＜0.05)，治疗组升高更明显；NT-proBNP浓度2组治疗后下降，治疗组下降更明显(P＜0.05)，结论：以心功能分级为依据的中医辨证分型治疗CHF疗效优于单纯西医治疗。
Abstract:
Objective: To observe clinical effects of TCM pattern therapy based on cardiac functional grading in treating chronic congestive heart failure (CHF). Methods: Sixty CHF patients were randomized into the treatment group and the control group, 30 cases each group, the control group received the therapy of western medicine, and the treatment group basic treatment of syndrome differentiation and treatment based on cardiac functional grading,four weeks one course, left ventricular ejection fraction (LVEF), NT-proBNP and total effective rate were observed after one course. Results: Total effective rate of the treatment group was 96.7%, higher than 83.3% of the control group, the difference had statistical meaning in the comparisons of total effective rates between both groups(P＜0.05); LVEF of both groups raised after treating (P＜0.05), the raise of the treatment group was more obvious; the concentrations of NT-proBNP lowered in both groups after treating, and the decrease of the treatment group was more obvious(P＜0.05). Conclusion: Clinical effects of syndrome differentiation and patterns based on cardiac functional grading are superior to only western medicine in treating CHF.

相似文献/References:

[1]李清秀,陈守强△.从运气学说探讨乙未年慢性心力衰竭的诊治规律[J].西部中医药,2015,28(10):84.
[2]刘明晖,赵树华△.五苓散治疗慢性心力衰竭60例[J].西部中医药,2017,30(02):74.
　LIU Minghui,ZHAO Shuhua.WuLing San in Treating 60 Cases of Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2017,30(09):74.
[3]李亮,姬艳苏△.黄芪总皂苷对心力衰竭大鼠JAK2和STAT3的影响[J].西部中医药,2018,31(09):17.
　LI Liang,JI Yansu.Effects of Total Saponins of HuangQi on JAK2/STAT3 of the Rats with Heart Failure[J].Western Journal of Traditional Chinese Medicine,2018,31(09):17.
[4]孙小静,张亚峰.参附注射液治疗慢性心力衰竭疗效观察[J].西部中医药,2019,32(05):84.
　SUN Xiaojing,ZHANG Yafeng.Clinical Observation on ShenFu Injection in the Treatment for Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2019,32(09):84.
[5]赵丽娴,袁天慧,陈汉裕.冼绍祥教授从“双心”角度论治慢性心力衰竭思想荟萃[J].西部中医药,2020,33(05):38.[doi:10.12174/j.issn.1004-6852.2020.05.11]
　ZHAO Lixian,YUAN Tianhui,et al.Professor Xian Shaoxiang′s Thinking of Treating Chronic Heart Failure Based on the Angle of ″Two Hearts″[J].Western Journal of Traditional Chinese Medicine,2020,33(09):38.[doi:10.12174/j.issn.1004-6852.2020.05.11]
[6]刘颖,李争,张玉焕,等.芪参益气汤联合厄贝沙坦治疗老年慢性心力衰竭临床观察[J].西部中医药,2020,33(06):98.[doi:10.12174/j.issn.1004-6852.2020.06.26]
　LIU Ying,LI Zheng,ZHANG Yuhuan,et al.Clinical observation on Qishen Yiqi Tang and Irbesartan in Treating Senile Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2020,33(09):98.[doi:10.12174/j.issn.1004-6852.2020.06.26]
[7]张洪磊,郝伟,张婷△.养心益阳汤对慢性心力衰竭患者IL-6、IL-18、hs-CRP水平的影响[J].西部中医药,2020,33(08):86.[doi:10.12174/j.issn.1004-6852.2020.08.22]
　ZHANG Honglei,HAO Wei,ZHANG Ting.Influence of Heart-nourishing Yang-invigorating Decoction on the Levels of IL-6,IL-18 and hs-CRP in CHF Patients[J].Western Journal of Traditional Chinese Medicine,2020,33(09):86.[doi:10.12174/j.issn.1004-6852.2020.08.22]
[8]李星星,李岩,范宗静,等.慢性心力衰竭合并焦虑抑郁的研究进展[J].西部中医药,2021,34(07):150.[doi:10.12174/j.issn.2096-9600.2021.07.38]
　LI Xingxing,LI Yan,FAN Zongjing,et al.Research Progress of Chronic Heart Failure with Anxiety and Depression[J].Western Journal of Traditional Chinese Medicine,2021,34(09):150.[doi:10.12174/j.issn.2096-9600.2021.07.38]
[9]冯思颖,吴威妮,褚庆民,等.基于网络药理学探讨葶苈大枣泻肺汤治疗慢性心力衰竭的作用机制[J].西部中医药,2021,34(05):26.[doi:10.12174/j.issn.2096-9600.2021.05.07]
　FENG Siying,WU Weini,CHU Qingmin,et al.The Mechanism of Tingli Dazao Xiefei Tang in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(09):26.[doi:10.12174/j.issn.2096-9600.2021.05.07]
[10]寿鑫甜,王禹萌,李学思,等.从辨证复杂性论慢性心力衰竭[J].西部中医药,2021,34(05):140.[doi:10.12174/j.issn.2096-9600.2021.05.36]
　SHOU Xintian,WANG Yumeng,LI Xuesi,et al.On Chronic Heart Failure from the Complexity of Syndrome Differentiation[J].Western Journal of Traditional Chinese Medicine,2021,34(09):140.[doi:10.12174/j.issn.2096-9600.2021.05.36]

备注/Memo

备注/Memo:
收稿日期：2017-10-04 作者简介：刘世梅(1980—)，女，硕士学位，主治医师。研究方向：心血管病的诊治。
更新日期/Last Update: 2018-09-15